ATRX

Healthcare Biotechnology

Adhera Therapeutics, Inc.

$0.00

-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap

722.09

Avg Volume

EPS

-$1.18

52W High

$0.01

52W Low

$0.00

Div. Yield

0.0%

Valuation

P/B Ratio

-0.00

PEG Ratio

1.84

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Assets

(532.9%)

Liquidity & Leverage

Current Ratio

0.00

Quick Ratio

0.00

Total Cash

32,388

Total Debt

10.83M

About

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

adherathera.com